US4428938A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Peptides affecting the immune regulation and a process for their preparation
Assignee: Richter Gedeon Vegyeszeti Gyar Nyrt
•
Filing: 1982-06-11
•
Granted: 1984-01-31
•
Expires: 2002-06-11
Abstract
Abstract Peptides affecting the immune regulation selected from the following group: Arg-Lys-Asp Arg-Lys-Asp-Val Arg-Lys-Asn-Val Arg-Lys-Asu-Val Arg-Lys-Ala-Val Arg-Lys-Asp-Ala Arg-Lys-Asp-Ile Arg-Lys-Glu-Val Arg-Ala-Asp-Val Arg-Asp-Lys-Val Ala-Lys-Asp-Val Lys-Arg-Asp-Val Glp-Arg-Lys-Asp Glp-Arg-Lys-Asp-Val Glp-Arg-Lys-Asp-Val-Tyr and salts, amides lower alkyl esters and protected derivatives thereof.
Inventors
- 👤 Lajos Kisfaludy
- 👤 Olga Nyeki nee Kuprina
- 👤 Istvan Schon
- 👤 Laszlo Denes
- 👤 Julia Ember
- 👤 Gyorgy Hajos
- 👤 Laszlo Szporny
- 👤 Bela Szende
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 18:16
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/08; C07K5/0815; A; A61; A61P; A61P37/00; C07K14/00; C07K14/435; C07K14/575; C07K14/66; C07K5/10; C07K5/1002; C07K5/1005; C07K5/1008; C07K5/1019; C07K5/1024; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/18
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
35 words
Peptides affecting the immune regulation selected from the following group: Arg-Lys-Asp Arg-Lys-Asp-Val Arg-Lys-Asn-Val Arg-Lys-Asu-Val Arg-Lys-Ala-Val Arg-Lys-Asp-Ala Arg-Lys-Asp-Ile Arg-Lys-Glu-Val Arg-Ala-Asp-Val Arg-Asp-Lys-Val Ala-Lys-Asp-Val Lys-Arg-Asp-Val Glp-Arg-Lys-Asp Glp-Arg-Lys-Asp-Val Glp-Arg-Lys-Asp-Val-Tyr and salts, amides, lower alkyl esters and protected derivatives thereof.
Claim 2
Dependent Claim
35 words
Peptides affecting the immune regulation selected from the following group: Arg-Lys-Asp Arg-Lys-Asp-Val Arg-Lys-Asn-Val Arg-Lys-Asu-Val Arg-Lys-Ala-Val Arg-Lys-Asp-Ala Arg-Lys-Asp-Ile Arg-Lys-Glu-Val Arg-Ala-Asp-Val Arg-Asp-Lys-Val Ala-Lys-Asp-Val Lys-Arg-Asp-Val Glp-Arg-Lys-Asp Glp-Arg-Lys-Asp-Val Glp-Arg-Lys-Asp-Val-Tyr and salts, amides, lower alkyl esters and protected derivatives thereof.
Claim 3
Dependent Claim
39 words
A method of treating an immunological disorder due to a deficiency in the thymus which comprises the step of administering to a subject in need of said treatment, a pharmaceutically effective amount of the compound defined in claim 1.
Claim 4
Dependent Claim
32 words
A method of regulating thymus hormonal levels, which comprises the step of administering to a subject in need of said regulation, a pharmaceutically effective amount of the compound defined in claim 1.
References Cited (Backward Citations)
US4190646A
Cited
US4261886A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-01-30 | 1987-08-01 | 1988-01-31 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-01-30 | 1991-08-01 | 1992-01-31 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-01-30 | 1995-08-01 | 1996-01-31 | $7700.00 | Window Closed / Lapsed |